Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
4.470
-0.020 (-0.45%)
Nov 4, 2024, 4:00 PM EST - Market closed
Tenax Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 15 | 7 | 5 | 26 | 23 | 10 | |
| Market Cap Growth | -9.64% | 31.60% | -81.01% | 11.69% | 146.95% | 160.44% | |
| Enterprise Value | 6 | -4 | 1 | 18 | 15 | 3 | |
| Last Close Price | 4.47 | 21.97 | 178.24 | 1664.00 | 2976.00 | 2256.00 | |
| PE Ratio | - | -0.71 | -0.30 | -0.66 | - | - | |
| PB Ratio | 0.99 | 0.81 | 3.34 | 6.18 | 5.07 | 2.52 | |
| P/FCF Ratio | -0.52 | -1.11 | -0.44 | -2.41 | -2.53 | -1.26 | |
| P/OCF Ratio | -0.52 | -1.11 | -0.44 | -2.41 | -2.53 | -1.26 | |
| EV/EBITDA Ratio | 0.48 | 0.54 | -0.13 | -0.58 | -1.53 | -0.30 | |
| EV/EBIT Ratio | 0.48 | 0.54 | -0.13 | -0.58 | -1.53 | -0.30 | |
| EV/FCF Ratio | 0.54 | 0.75 | -0.12 | -1.67 | -1.63 | -0.34 | |
| Debt / Equity Ratio | 0.03 | 0.06 | 0.54 | 0.07 | 0.07 | 0.05 | |
| Debt / FCF Ratio | -0.02 | -0.08 | -0.07 | -0.03 | -0.03 | -0.02 | |
| Quick Ratio | 5.39 | 2.73 | 1.15 | 3.57 | 3.17 | 2.13 | |
| Current Ratio | 6.10 | 3.26 | 1.74 | 3.64 | 3.21 | 2.44 | |
| Return on Equity (ROE) | -113.79% | -160.79% | -385.12% | -732.21% | -234.61% | -108.01% | |
| Return on Assets (ROA) | -66.09% | -68.21% | -147.02% | -306.43% | -93.21% | -54.28% | |
| Return on Capital (ROIC) | -71.73% | -94.43% | -202.10% | -416.33% | -138.99% | -68.05% | |
| Earnings Yield | -82.51% | -117.67% | -221.89% | -123.88% | -41.97% | -88.32% | |
| FCF Yield | -75.16% | -90.09% | -228.77% | -41.43% | -39.52% | -79.54% | |
| Buyback Yield / Dilution | -766.16% | -1250.92% | -43.00% | - | - | - | |
| Total Shareholder Return | -766.16% | -1250.92% | -43.00% | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.